摘要
目的 :评估 Wiktor- Gx Hepamed冠状动脉内支架的临床疗效。方法 :对 15例不稳定型心绞痛患者植入冠状动脉内支架。植入支架的压力为 (982 .9± 182 .4) k Pa。术后即刻残余狭窄 (10 .3± 9.8) % ,支架术的急性获得 (1.96± 0 .5 1) m m,后期丢失 (0 .5 8± 0 .91) mm。术后未给肝素和华法令 ,仅服抗血小板药物。结果 :术后住院 (3± 1) d。随访 (378± 6 6 ) d,其中 2例再狭窄。在住院期和随访期 ,无一例发生严重心脏事件及出血、血栓形成、再阻塞。结论 :非高压扩张和无抗凝的 Wiktor- GX Hepamed冠状动脉内支架术是安全和有效的。
Objective:To evaluate the clinical effect of the preliminary experience with the Wiktor-Gx Hepamed coronary stent for treatment of unstable angina pectoris(UAP).Method:From Nov 1997 to Jul 1998,forteen patients with UAP underwent the stent implantaion after angioplasty.The stent delivery was successful in all patients(100%),and mean pressure of balloon inflations was ( 982.9 ± 182.4 )kPa.Residuanl stenosis after stenting was ( 10.3 ± 9.8 )%,acute gain ( 1.96 ± 0.51 )mm,and late loss ( 0.58 ± 0.91 )mm.The postprocedural regimen consisted of aspirin and ticlopidine but without warfarin and heparin.Result:The mean hospital stay after stenting was (3±1)d.The mean clinical follow-up period was (378±66)d.There were 15 percent of restenosis,but no other major cardial event,and no bleeding,thrombosis and reocclusion occurred in all patients.Conclusion:Shor and long-term clinical and angiographic outcomes are favorable in patients wih UAP undergoing Wicktor Gx hepamed-stent implantation without use of adjunctive high-pressure poststenting inflation and anticoagulant.
出处
《临床心血管病杂志》
CAS
CSCD
北大核心
2000年第11期509-511,共3页
Journal of Clinical Cardiology
